-
Peptide Aggregation by 1H NMR and All-Atom MD
2026-09-24
This study paired solution-state 1H NMR with all-atom molecular dynamics to compare aggregation in structurally related therapeutic peptides. NMR detected changes in aggregate populations and counterion association, while simulations reproduced the experimental rank order for the peptides modeled and offered molecular-level insight into self-assembly. The complementary approach may help identify aggregation risks during early peptide formulation work.
-
Bay 11-7085: NF-κB Convergence in Brain Injury
2026-09-24
Explore how Bay 11-7085 can help interrogate NF-κB convergence in early brain injury research. This article connects neuritin and ER-stress findings after subarachnoid hemorrhage with practical experimental questions—while distinguishing pathway evidence from compound validation.
-
Busulfan and the Logic of Lineage-Tracing Evidence
2026-09-23
Busulfan is a DNA alkylating agent used to perturb cells, but injury alone cannot prove regeneration. This article examines how dual-recombinase tracing separates cellular damage from lineage replacement—and what that means for interpreting ovarian assays.
-
Biotin-HPDP for Redox Protein Workflows
2026-09-23
Biotin-HPDP converts accessible protein thiols into a reversible affinity handle for streptavidin capture, release, and redox-state comparison. This practical workflow connects thiol labeling with SELENOK–CD36 biology while distinguishing validated assay steps from hypothesis-generating applications.
-
Rotavirus Infection and Nrf2 Redox Defense
2026-09-22
The 2020 reference study identifies a biphasic response in which rotavirus initially activates Nrf2 during an oxidative-stress burst but subsequently drives Nrf2 depletion, nuclear loss, and suppression of antioxidant transcription. Its time-resolved design links late Nrf2 downregulation to proteasome-associated, K48-linked ubiquitination rather than simply to canonical Keap1-mediated turnover.
-
Camostat Mesilate and the Next Era of Protease Translation
2026-09-22
A mechanistic and translational strategy for using Camostat Mesilate to connect ENaC biology, fibrosis signaling, and next-generation protease inhibitor design without overextending the evidence.
-
N2703 in Adipose-Neural Cardiac Assays
2026-09-21
Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as an exploratory perturbation tool in adipocyte–neuron–cardiomyocyte models. Its strong solvent compatibility supports dose-response, conditioned-media, and pathway-dissection workflows while keeping interpretation separate from the reference study’s validated leptin–NPY mechanism.
-
Oteseconazole (VT-1161) Research Workflows
2026-09-21
Build reproducible Candida susceptibility, resistance, and exposure-response studies with Oteseconazole (VT-1161), a selective tetrazole CYP51 inhibitor. This guide distinguishes evidence-backed performance from practical assay recommendations, including solvent handling, MIC design, comparator selection, and troubleshooting.
-
Amitriptyline HCl: Practical Assay Workflow
2026-09-20
Amitriptyline HCl (SKU B2231) provides a defined, soluble small-molecule probe for receptor-inhibition assays, neurotransmitter receptor modulation studies, and controlled neuropharmacology research workflows. Use it for in vitro pharmacology and model-system experiments with appropriate vehicle and viability controls; do not treat dossier potency values as clinical efficacy, disease-model validation, or universal activity constants.
-
Nurr1+ Neuron Development in the Rat Claustrum
2026-09-19
Fang, Wang, and Naumann mapped the prenatal emergence and birth timing of Nurr1-positive neurons across the rat claustrum and lateral cortex. By combining EdU birth dating with Nurr1 in situ hybridization, the study resolved sequential neurogenesis and spatial gradients that help refine anatomical definitions of claustral subregions.
-
HyperScribe™ SP6 High Yield RNA Synthesis Kit
2026-09-18
The HyperScribe™ SP6 High Yield RNA Synthesis Kit enables controlled RNA production for probe design, RNA interference experiments, and immune-pathway research. This article examines how transcript identity, labeling, and contaminant control can determine the interpretation of stress-granule and innate-immunity assays.
-
Amitriptyline HCl: Systems Assay Framework
2026-09-18
Amitriptyline HCl can serve as a precise pharmacology probe when receptor affinity, cellular context, and orthogonal readouts are interpreted together. This article connects its neuropharmacology applications with lessons from recent RGNNV lipidomics research without overstating cross-domain evidence.
-
Nurr1 Neurogenetic Gradients in the Rat Claustrum
2026-09-17
Fang, Wang, and Naumann mapped the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum and lateral cortex. By combining developmental expression analysis with EdU birth dating and Nurr1 in situ hybridization, the study resolves region-specific neurogenetic sequences and provides a framework for interpreting claustral organization.
-
Hexa His tag peptide: Smarter Elution Design
2026-09-17
Hexa His tag peptide enables a cleaner, competition-based route for eluting His-tagged proteins from anti-His immunoprecipitation workflows. This guide connects its molecular mechanism with sequence-aware protein interaction analysis and practical assay decisions.
-
Endothelial SGK1 Mediates Vascular Stiffening
2026-09-16
Zhang et al. identify endothelial SGK1 as a mechanistic link between mineralocorticoid–salt exposure, sodium-channel activity, actin remodeling, and vascular stiffening. By combining endothelial-specific genetics with pharmacological inhibition in human aortic endothelial cells, the study supports SGK1 as a target for mechanistic hypertension and vascular biology research.